266 related articles for article (PubMed ID: 1422305)
1. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
Ke HZ; Li M; Jee WS
Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
3. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
Ke HZ; Chen HK; Qi H; Pirie CM; Simmons HA; Ma YF; Jee WS; Thompson DD
Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats.
Ma YF; Ke HZ; Jee WS
Bone; 1994; 15(2):137-46. PubMed ID: 8086230
[TBL] [Abstract][Full Text] [Related]
5. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
Ito H; Ke HZ; Jee WS; Sakou T
Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
[TBL] [Abstract][Full Text] [Related]
6. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
7. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.
Mori S; Jee WS; Li XJ
Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875
[TBL] [Abstract][Full Text] [Related]
8. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
[TBL] [Abstract][Full Text] [Related]
10. Bipedal stance exercise enhances antiresorption effects of estrogen and counteracts its inhibitory effect on bone formation in sham and ovariectomized rats.
Chen JL; Yao W; Frost HM; Li CY; Setterberg RB; Jee WS
Bone; 2001 Aug; 29(2):126-33. PubMed ID: 11502473
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
[TBL] [Abstract][Full Text] [Related]
12. Bipedal stance exercise and prostaglandin E2 (PGE2) and its synergistic effect in increasing bone mass and in lowering the PGE2 dose required to prevent ovariectomized-induced cancellous bone loss in aged rats.
Mo A; Yao W; Li C; Tian X; Su M; Ling Y; Zhang Q; Setterberg RB; Jee WS
Bone; 2002 Sep; 31(3):402-6. PubMed ID: 12231413
[TBL] [Abstract][Full Text] [Related]
13. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone and low dose estrogen on bone growth and turnover in long bones of hypophysectomized rats.
Kidder LS; Schmidt IU; Evans GL; Turner RT
Calcif Tissue Int; 1997 Oct; 61(4):327-35. PubMed ID: 9312204
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
Jee WS; Mori S; Li XJ; Chan S
Bone; 1990; 11(4):253-66. PubMed ID: 2242291
[TBL] [Abstract][Full Text] [Related]
17. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.
Turner RT; Evans GL; Cavolina JM; Halloran B; Morey-Holton E
Endocrinology; 1998 Oct; 139(10):4086-91. PubMed ID: 9751486
[TBL] [Abstract][Full Text] [Related]
18. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
Ma Y; Chen YY; Jee WS; Ke HZ; Ijiri K
Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927
[TBL] [Abstract][Full Text] [Related]
19. Effect of combined teriparatide and monthly minodronic acid therapy on cancellous bone mass in ovariectomized rats: a bone histomorphometry study.
Iwamoto J; Seki A; Sato Y
Bone; 2014 Jul; 64():88-94. PubMed ID: 24727162
[TBL] [Abstract][Full Text] [Related]
20. Mechanical loading modifies ovariectomy-induced cancellous bone loss.
Lin BY; Jee WS; Chen MM; Ma YF; Ke HZ; Li XJ
Bone Miner; 1994 Jun; 25(3):199-210. PubMed ID: 8086858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]